VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
VB100
Services
About VCBeat
Why VCBeat
Log In
Home
Wecare Probiotics Files for HKEX IPO: China’s Top Probiotic Strain Innovator Reports 28.9% Revenue Growth in 2025
Wecare Probiotics Files for HKEX IPO: China’s Top Probiotic Strain Innovator Reports 28.9% Revenue Growth in 2025
CST Updated Apr 29, 2026 10:04
Share: